Literature DB >> 31447333

Percutaneous image-guided ablation: From techniques to treatments.

Fourat Ridouani1, Govindarajan Srimathveeravalli2.   

Abstract

Image-guided ablation is performed by percutaneously introducing ablation probes to deliver energy into a tumor to destroy it in a controlled and localized fashion. Ablation modalities can be broadly classified as thermal or non-thermal based on the mechanism of tumor destruction and are performed using different types of image guidance for planning, delivering and follow-up of the treatment. Ablation is performed in a minimally invasive fashion, providing greater residual organ preservation with minimal morbidity to the patient. Image-guided ablation is being used in the clinic for the treatment of primary and metastatic tumors, and this article reviews state of the art for the treatment of malignancies in the liver, lung, kidney and musculoskeletal tissue.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31447333     DOI: 10.1016/j.lpm.2019.06.005

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  Numerical analysis of three-dimensional echo decorrelation imaging.

Authors:  Michael T Cox; Mohamed A Abbass; T Douglas Mast
Journal:  J Acoust Soc Am       Date:  2020-06       Impact factor: 1.840

Review 2.  Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors.

Authors:  Arian Mansur; Tushar Garg; Apurva Shrigiriwar; Vahid Etezadi; Christos Georgiades; Peiman Habibollahi; Timothy C Huber; Juan C Camacho; Sherif G Nour; Alan Alper Sag; John David Prologo; Nariman Nezami
Journal:  Diagnostics (Basel)       Date:  2022-05-24

3.  Radiologic-pathologic analysis of increased ethanol localization and ablative extent achieved by ethyl cellulose.

Authors:  Erika Chelales; Robert Morhard; Corrine Nief; Brian Crouch; Jeffrey I Everitt; Alan Alper Sag; Nirmala Ramanujam
Journal:  Sci Rep       Date:  2021-10-19       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.